Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Swainsonine: a new antineoplastic immunomodulator.

S Mohla, M J Humphries, S L White

    Journal of the National Medical Association
    |October 1, 1989
    PubMed
    Summary

    Swainsonine, an indolizidine alkaloid, effectively inhibits cancer metastasis and primary tumor growth in mice and humans. This compound shows promise for future cancer therapies due to its unique anti-cancer properties.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    LUMBAR syndrome-OEIS complex overlap: A case series and review.

    American journal of medical genetics. Part A·2024
    Same author

    Prognostic value of temporal patterns of left atrial reservoir strain in patients with heart failure with reduced ejection fraction.

    Clinical research in cardiology : official journal of the German Cardiac Society·2023
    Same author

    Lessons learned from a comprehensive electronic patient record procurement process-implications for healthcare organisations.

    BMJ health & care informatics·2019
    Same author

    Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials.

    Blood·2018
    Same author

    Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome.

    Journal of internal medicine·2016
    Same author

    Baseline Frailty Evaluation in Drug Development.

    The Journal of frailty & aging·2016

    Area of Science:

    • Biochemistry
    • Immunology
    • Oncology

    Background:

    • Swainsonine is an indolizidine alkaloid.
    • It possesses known immunomodulatory activity.

    Purpose of the Study:

    • To evaluate the efficacy of swainsonine in inhibiting cancer.
    • To assess its effects on metastatic dissemination and primary tumor growth.

    Main Methods:

    • Studies were conducted on both murine and human cancer models.
    • The antimetastatic, anti-proliferative, and immunomodulatory activities of swainsonine were investigated.

    Main Results:

    • Swainsonine demonstrated effectiveness in inhibiting the metastatic spread of cancer.
    • It also showed efficacy in suppressing the growth of primary tumors.

    Related Experiment Videos

  • The compound's immunomodulatory effects contributed to its anti-cancer activity.

    • Conclusions:

    • Swainsonine exhibits significant antimetastatic and anti-proliferative properties.
    • Its unique combination of activities suggests a promising role in cancer treatment.
    • Further research into swainsonine for cancer therapy is warranted.